Women At Risk: The High Risk Breast Cancer Program (WAR)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01034891
Verified October 2009 by New York Presbyterian Hospital. Recruitment status was: Recruiting
The purpose of this study is to increase understanding of women who are at high risk for developing breast cancer. Data from this group will be collected and entered into a registry. This registry serves as a clinical database to support research in prevention, early detection and treatment of breast cancer.
Condition or disease
This is a longitudinal cohort study that collects data of eligible women at risk for developing breast cancer. Patient information will be entered into a secured computerized database that is used for research on the prevention, early detection and treatment of breast cancer.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients of the breast center at New York Presbyterian Hosptial/ Columbia University Medical Center
one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal breast cancer
two or more first-degree relatives with post-menopausal breast cancer
tested positive for a BRCA1 or BRCA2 mutation
a history of biopsy-proven atypical ductal hyperplasia or atypical lobular hyperplasia
a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)